جست‌وجوی استاد و پژوهشگر

• Obesity Research
• Endocrinology
• Diabetes Mellitus
• +۳ مورد دیگر

Felipe Casanueva Freijo is a Researcher at the Universidad Complutense de Madrid, affiliated with the Department of Psychiatry, Radiology, Public Health, Nursing and Medicine under the Faculty of Medicine and Dentistry. His research spans obesity, diabetes, endocrinology, and metabolic disorders, with a focus on nutritional interventions, epigenetic mechanisms, and hormonal pathways. He holds a doctoral degree from the Universidad Complutense de Madrid (1977), where his thesis explored growth hormone regulation. Key research interests include the efficacy of ketogenic diets, vitamin D supplementation post-bariatric surgery, and the pathophysiology of pituitary tumors such as acromegaly and prolactinomas. He has contributed to international consensus statements on diagnostic standards for acromegaly and Cushing’s disease, emphasizing multidisciplinary care pathways. His work bridges clinical endocrinology with public health, analyzing global trends in diabetes prevalence and obesity-related comorbidities through large-scale epidemiological studies. Publications highlight his exploration of biomarkers like osteopontin and INSL3, molecular mechanisms linking obesity to accelerated epigenetic aging, and the role of dietary interventions in modulating metabolic and inflammatory markers. Collaborations focus on pituitary tumor centers of excellence (PTCOEs), advancing standardized treatment protocols for hormonal disorders. His research underscores translational applications, aiming to optimize medical management through evidence-based strategies.

Robert A Edwardsمشاهده پروفایل

استاد

• Colitis and Colon Cancer
• Tumor Microenvironment
• Metabolic Imaging
• +۷ مورد دیگر

Robert A. Edwards, MD, PhD, is a Professor in the Department of Pathology & Laboratory Medicine at the University of California, Irvine (UCI) School of Medicine. He is board-certified in Anatomic and Clinical Pathology and specializes in molecular and autopsy pathology. His clinical and research work is centered at UCI Medical Center in Orange, CA. PhD in Cell Biology, Baylor College of Medicine, 1995 MD, Baylor College of Medicine, 1997 Residency: Anatomic & Clinical Pathology, Baylor College of Medicine Post-Doctoral Fellowship, University of Michigan Dr. Edwards' research focuses on the molecular mechanisms of colitis and colon cancer, particularly how inflammation, metabolic reprogramming, and the tumor microenvironment contribute to carcinogenesis. His work integrates molecular pathology, immunology, and systems biology to understand disease progression and identify therapeutic targets. Key areas include Wnt signaling, metabolic imaging, and host-microbe interactions in the gut. His recent publications reveal a strong trend in cancer metabolism, inflammation, and microbial pathogenesis, with studies published in Nature , Cell Host & Microbe , and JCI . These works highlight the interplay between immune responses, nutrient availability, and tumor growth in colorectal cancer. Scientific contributions include: Patent on monoclonal anti-thioredoxin antibodies NIH-funded research on Wnt and metabolism in colon cancer Key findings on calprotectin, iron/manganese sequestration, and bacterial survival in the inflamed gut Dr. Edwards is actively involved in mentoring and graduate education, serving in the Pathology-Anatomic and Clinical PhD program. He has held significant roles in NIH-funded grants, including as Co-Investigator on a U54 Cancer Systems Biology Center and as Shared Resource Core Director for the NCI Cancer Center Support Grant. His collaborative research spans immunology, cancer biology, and metabolic regulation. He is affiliated with the Chao Family Comprehensive Cancer Center and contributes to both clinical diagnostics and translational research. His lab employs advanced techniques in molecular pathology, fluorescence lifetime imaging, and animal models of gastrointestinal disease.

• Immunometabolism
• Cancer Biology
• Skin Biology
• +۶ مورد دیگر

Simon-Pierre Gravel is an Associate Professor at the University of Montreal's Faculté de pharmacie. He holds a PhD in Pharmacy (2011) and completed postdoctoral training at McGill University (2016), focusing on breast cancer metabolism and skin aging. His research investigates the metabolic basis of inflammation in chronic diseases, cancer, and viral infections, with a focus on PGC-1 coactivators' roles in linking cellular metabolism to immune activation. He leads studies on immunometabolism in melanoma and skin aging, supported by grants from the Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering Research Council (NSERC), and the Canadian Cancer Society. Education: PhD in Pharmacy (University of Montreal, 2011), Postdoc at McGill University's Goodman Cancer Research Centre (2016) Research interests include: 1) PGC-1 family proteins' regulation of mitochondrial biology and transcriptional programs, 2) Metabolic drivers of immunosuppression in cancer, 3) Development of therapies targeting metabolism-inflammation axis. His lab has identified stress-induced PGC-1 downregulation as a pro-inflammatory trigger in skin and melanoma contexts. Recent work highlights mitochondrial biogenesis rheostat functions in skin aging and immunometabolic landscapes, with projects funded through NSERC (2023-2029), CIHR (2021-2028), and cancer-focused grants. Over 15 students have been mentored since 2018, including master's theses on PGC-1β modulation and immunotherapy response. Key grants include a 2023 NSERC Discovery Grant for skin aging studies and a 2023 Canadian Cancer Society grant targeting melanoma immunometabolism. He also collaborates on nanoparticle delivery systems for gene therapy and anti-inflammatory drugs. Administrative roles include committee work for the BSc in Biopharmaceutical Sciences program and biosafety oversight. Editor for Metabolites (2019), and peer reviewer for multiple national funding agencies.

• Molecular Plant Pathology
• Fungicide Resistance
• Third-Generation DNA Sequencing
• +۵ مورد دیگر

Dr. Katherine Zulak is a Lecturer at Curtin University's School of Molecular and Life Sciences within the Faculty of Science and Engineering. Her research focuses on molecular plant pathology, particularly fungicide resistance in agricultural crops. She develops innovative tools using third-generation DNA sequencing (e.g., Oxford Nanopore) for real-time monitoring of pathogen resistance. Her work emphasizes barley phytopathogens like Pyrenophora teres and wheat stripe rust, with applications in sustainable agriculture and disease management. Her research also extends to plant-microbe interactions, including studies on aphid-legume interactions and conifer defense mechanisms. She has contributed to understanding terpenoid biosynthesis pathways in sandalwood and opium poppy, exploring metabolic reprogramming in elicitor-treated cultures. Her methodologies include proteomics, metabolomics, and next-generation sequencing technologies. Key Contributions: Development of portable DNA sequencing for field-based resistance monitoring Characterization of fungal secretomes and pathogen virulence factors Metagenomic analysis of crop microbiomes Integration of omics data for plant defense studies Dr. Zulak collaborates with industry partners to translate molecular insights into practical solutions for crop protection. Her work bridges fundamental research and agricultural applications, addressing global challenges in sustainable crop production.

• Pediatrics
• Clinical Research
• Neurodevelopmental Disorders
• +۷ مورد دیگر

Ana Checa Ros is a Spanish Associate Professor at CEU Cardenal Herrera University's Department of Medicine and Surgery, with dual expertise in clinical pediatrics and biomedical research. Holding a Cum Laude PhD in Medicine from the University of Granada (2017) and a six-year research grant from CENAI (2023), she leads the emerging Cardiorenal and Metabolic Diseases research group alongside Dr. D'Marco. Medical Degree: University of Granada (End of Degree Award, 2011) PhD: Cum Laude, University of Granada (2017) Postdoctoral Research: Aston University (2019-2021) Her research focuses on melatonin's anti-inflammatory/antioxidant properties, particularly in neurodevelopmental disorders and chronic kidney disease. She has coordinated clinical trials like NCT04076410 for photosensitive epilepsy and participated in the H2020 DYNAHealth project investigating maternal nutrition effects on neurodevelopment. Scientific contributions include 15+ JCR-indexed publications (2020-2025) spanning cardiorenal diseases, ADHD neuroimmunology, and metabolic disorders. Her work combines clinical practice with translational research, maintaining active teaching roles since 2012 and serving as guest editor for journals like Healthcare. End of Degree Award (University of Granada, 2011) Cum Laude Doctoral Thesis (University of Granada, 2017) CENAI Six-Year Research Grant (2023)

Michael Glickmanمشاهده پروفایل

استاد

• Mycobacterial Biology
• Infectious Diseases
• Cancer Immunotherapy
• +۴ مورد دیگر

Michael Glickman is a Professor at Memorial Sloan Kettering Cancer Center (MSKCC) with a dual appointment in the Department of Medicine and Gerstner Sloan Kettering Graduate School of Biomedical Sciences . He holds an MD from Columbia University College of Physicians and Surgeons and leads the Michael Glickman Lab, focusing on mycobacterial biology, tuberculosis pathogenesis, and BCG immunotherapy mechanisms. Research Interests : Mycobacterial proteostasis systems DNA repair and mutagenesis BCG-induced anti-tumor immunity Microbiome-tuberculosis interactions Key Article Trends : 2025 studies highlight ALFA tagging, metal resistance, and immune reprogramming 2024 work explores TNF deficiency in TB and DnaK-GrpE structural dynamics 2023 research addresses Rip1 protease roles in metal homeostasis Labs & Collaborations : Immunology Program Collaborations with Weill Cornell Medicine and GHESKIO Center Active postdoctoral opportunities Advising & Grants : Mentors PhD students and postdocs; funded by NIH grants AI53417 , R01 AI080628 , and P30 CA008748 . His lab investigates host immune sensing, microbiome dynamics, and mycobacterial virulence pathways.

• DNA Repair
• Cancer Biology
• Molecular Biology
• +۵ مورد دیگر

Hailiang Hu is a tenure-track Associate Professor at Southern University of Science and Technology's School of Medicine. He holds a PhD in Biochemistry & Molecular Biology from Chinese Academy of Sciences and completed postdoctoral training at UCLA. His career includes roles at Duke University (Assistant Professor) and UCLA (Assistant Researcher/RAP) with grants from NIH, DoD, and California-based programs. Education : BS in Chemistry (Nankai University) and PhD in Biochemistry & Molecular Biology (CAS) Research Focus : DNA repair mechanisms, tumor metabolism reprogramming, and non-coding RNA roles in therapy-resistant GU cancers. His prostate cancer work explores castration resistance and neuroendocrine trans-differentiation, while iPSC studies address Ataxia-Telangiectasia neurodegeneration. Current projects target biomarker discovery and radiosensitizer development. Publication Trends : 15-year span shows concentration on miRNA/DNA repair (2000-2017), prostate cancer metabolism (2010-2021), and therapy resistance mechanisms (2005-2021). Key journals include PNAS, Nature Communications, and Molecular Cancer. Scientific Awards : PCF Movember Valor Challenge Award (2018) California BCRP IDEA Award (2011) UCLA Postdoctoral Excellence Award (2006) JCCF Postdoctoral Fellowship (2003) Proctor & Gamble Baojie Award (2000) Advisory Roles : Guest Editor at Frontier in Pharmacology and peer reviewer for 15+ journals including Clinical Cancer Research and DNA Repair. Labs & Collaborations : Leads research at SUSTech's School of Medicine, with prior affiliations at Duke Pathology Department and UCLA's Jonsson Cancer Center.

Jeffrey Biernaskieمشاهده پروفایل

استاد

• Stem Cells
• Tissue Regeneration
• Wound Healing
• +۳ مورد دیگر

Dr. Jeffrey Biernaskie is a Full Professor at the University of Calgary's Faculty of Veterinary Medicine, where he holds the Calgary Firefighters Burn Treatment Society Chair in Skin Regeneration and Wound Healing. He serves as Director of the Centre for Cell Therapy Translation and Chair of the Reproduction and Regenerative Medicine Research Group. His affiliations include the Hotchkiss Brain Institute and Alberta Children's Hospital Research Institute. Education: BSc in Neuro Psychology (University of Lethbridge, 1998) PhD in Neuroscience (Memorial University, 2004) Postdoctoral Fellowship in Skin and neural stem cell biology (The Hospital for Sick Children, 2009) Research Focus: Dr. Biernaskie investigates cellular and molecular mechanisms governing fibrotic versus regenerative healing, aiming to restore organ function post-injury. His lab studies how skin/brain stem cells are regulated during homeostasis and how injury, aging, and immunity impact their function. Key areas include stem cell reprogramming, immune modulation of regeneration, and single-cell analysis of tissue repair. Publication Trends: His recent work emphasizes regenerative medicine innovations, particularly in skin/brain repair, using advanced techniques like spatial transcriptomics and single-cell genomics. Themes include stem cell plasticity, immune-microenvironment interactions, biomaterial applications, and translational models of wound healing. Awards & Honors: Killam Professor (2024) Royal Society of Canada College Scholar (2019) CIHR New Investigator Award (2011) Multiple postdoctoral fellowships and early-career recognitions Leadership: Dr. Biernaskie directs the Biernaskie Lab, an interdisciplinary team exploring stem cell biology and tissue regeneration. The lab collaborates across neuroscience, immunology, and bioengineering to develop therapies for burns, nerve injuries, and degenerative conditions.

John Denuمشاهده پروفایل

استاد

• Epigenetics
• Metabolism
• Chromatin Remodeling
• +۷ مورد دیگر

John Denu is a Professor at the University of Wisconsin–Madison leading the Denu Laboratory, which is part of the Microbiome, Epigenetics, and Multi-omics hubs at the Wisconsin Institute for Discovery. His research program investigates the molecular connections between metabolism and epigenetic pathways in human health and age-associated diseases. The lab employs biochemical, genetic, and multi-omics approaches to study chromatin dynamics, utilizing mammalian tissue culture systems and mouse models. Denu's research interests center on understanding how metabolic pathways influence epigenetic regulation. His work focuses on three primary areas: the molecular links between metabolism and epigenetic pathways; the biochemical principles governing epigenetic information written onto histones; and the role of sirtuins in reversible protein acetylation. His lab explores how chromatin remodeling enzymes rely on metabolite-derived co-enzymes, suggesting coordination between nuclear events and metabolic networks. He investigates the hypothesis that chromatin modifying complexes have evolved to sense metabolite levels and respond accordingly. Analysis of his recent publications reveals a strong focus on metabolism-epigenome interactions, with particular emphasis on sirtuins, histone modifications, and the role of specific metabolites like citrate and short-chain fatty acids in regulating chromatin function. His work spans from fundamental biochemical mechanisms to disease-relevant models, particularly in neurodegeneration and aging. Denu mentors several graduate students including Jessica Han (who recently defended her PhD on diet, gut microbiome, and metabolism converging to remodel epigenetics) and Kellen Biesbrock (who joined in 2025). His lab actively collaborates with researchers across campus, including with Prof. Federico E. Rey in the Department of Bacteriology. The Denu Laboratory employs an interdisciplinary approach spanning basic biochemistry to big data, using methods ranging from in vitro enzyme assays to high-throughput mass spectrometry. The lab is actively involved in many collaborations both on and off campus, reflecting the integrative nature of metabolism-epigenome research.

• Endocrinology
• Thyroid Diseases
• Autoimmune Thyroiditis
• +۴ مورد دیگر

Camilla Virili is an Associate Professor at the Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome. She specializes in endocrinology with a focus on thyroid disorders, levothyroxine therapy optimization, and thyroid-autoimmune interactions. Academic Rank: Associate Professor Affiliation: Sapienza University of Rome Research Focus: Thyroid diseases, hormone metabolism, microbiota-endocrine interactions Scientific Contributions : Her work explores: Thyroid cancer risk stratification (ATA Score validation) Softgel levothyroxine formulation efficacy Thyroid-microbiota interplay ALK inhibitors in anaplastic thyroid cancer Thyroid dysfunction in non-thyroid autoimmune conditions Notable Publications (2022-2025): Systematic reviews on microbiota-thyroid connections, clinical studies on levothyroxine dosage optimization, and in vitro analyses of targeted cancer therapies.

Baohong Zhaoمشاهده پروفایل

استاد

• Bone biology
• Osteoclastogenesis
• Inflammatory signaling
• +۳ مورد دیگر

Baohong Zhao, MD, PhD, is Professor of Biochemistry in Medicine at Weill Cornell Medical College (2024–present). She earned her DMD (2001) and BM (1999) from Peking University and her PhD from Showa University Graduate School, Japan (2008). Her research focuses on molecular mechanisms governing bone homeostasis, osteoclastogenesis, and inflammatory signaling in skeletal and immunological contexts. Education Ph.D. — Showa University Graduate School (Japan), 2008 D.M.D. — Peking University (China), 2001 B.M. — Peking University Health Science Center (China), 1999 Research Interests Professor Zhao’s laboratory integrates bone biology, immunology, and epigenetics to dissect how osteoclasts and osteoblasts communicate with immune cells. Key themes include: Long non-coding RNA Malat1 as a master regulator of bone repair and β-catenin signaling Transcription factor RBP-J in macrophage polarization and osteoclast differentiation TGFβ and TNF crosstalk driving inflammatory bone resorption MicroRNA networks controlling osteoclastogenesis and skeletal remodeling Adipoq-lineage progenitors as critical sources of M-CSF in bone marrow niches Her work leverages conditional knockout mouse models, single-cell transcriptomics, and pharmacological inhibitors to translate findings into therapeutic targets for osteoporosis, Paget’s disease, and inflammatory arthritis. Publications Overview Since 2008, Professor Zhao has published >70 peer-reviewed articles, including high-impact studies in Nature Medicine , Nature Communications , Journal of Experimental Medicine , and Immunity . Recent work (2022-2025) highlights novel roles for lncRNAs, epigenetic regulators, and cytokine circuits in bone-immune interactions, collectively advancing understanding of skeletal diseases and identifying potential therapeutic avenues. Scientific Awards & Honors No specific awards are listed in the provided text. Advising & Funding No explicit information on current students or grant numbers is provided. Laboratory & Teams Professor Zhao leads an active research group at Weill Cornell Medical College, integrating molecular biology, immunology, and translational orthopedics to explore skeletal health and disease.

Iliyan D Ilievمشاهده پروفایل

دانشیار

• Immunology
• Mycology
• Microbiome
• +۳ مورد دیگر

Iliyan D Iliev is an Associate Professor in the Department of Medicine at Weill Cornell Medical College, where he has been affiliated since 2020. He holds a Ph.D. in Immunology from the University of Milan (2009) and M.Sc./B.Sc. degrees from Plovdiv University "Paisii Hilendarski". His research program investigates host-fungal interactions, with emphasis on: Mycobiota regulation of mucosal immunity in inflammatory bowel disease Fungal-bacterial transkingdom dynamics in cancer pathogenesis Commensal fungi as modulators of systemic immunity Immunoglobulin-mediated control of fungal colonization His 15 most recent publications (2023-2025) demonstrate convergent themes: fungal influences on immune cell function (neutrophils, T cells), gut-barrier integrity, and disease mechanisms in IBD/cancer. Methodologically, they integrate gnotobiotic models, multi-omics, and clinical translational approaches. Research funding includes $10M+ grants from NIH and private foundations: NIAID: Gut metabolite transkingdom interactions (2024-2029) NCI: Mycobiome role in cancer (2024-2029) Rainin Foundation: Fungal-bacterial therapeutics for UC (2024-2026) NIDDK: Commensal fungi in immunity (2023-2027) Cancer Research Institute: Lloyd J. Old STAR Program (2022-2027)

• Immunology
• Allergy and Asthma Research
• Dendritic Cell Biology
• +۳ مورد دیگر

Dr. John Gordon is a Professor at the College of Medicine , University of Saskatchewan , specializing in translational immunology . His research focuses on harnessing dendritic cells to suppress hyper-sensitive immune responses, with breakthrough applications in asthma , food allergies , and autoimmune diseases . He leads the Respiratory Research Centre, emphasizing collaborative strategies to advance immunotherapeutic solutions for respiratory conditions affecting millions of Canadians. Therapeutic Innovation: Reprogrammed dendritic cells reduce airway inflammation by 90% in preclinical models. Clinical Translation: Work extends to autoimmune diseases like Multiple Sclerosis via regulatory T cell mechanisms. Collaborative Vision: Advocates for resource-sharing through the Respiratory Research Centre to accelerate scientific breakthroughs. His publications span chemokine antagonism , dendritic cell therapy , and inflammatory disease models , with key contributions to allergy immunology and cancer treatment. Current efforts involve clinical trials for allergen-specific tolerance induction and interdisciplinary exploration of respiratory health challenges.

Meike Burowمشاهده پروفایل

استاد

• Plant Metabolism
• Regulatory Networks
• Glucosinolate Biosynthesis
• +۴ مورد دیگر

Meike Burow serves as Professor in the Department of Plant and Environmental Sciences within the Faculty of Science at the University of Copenhagen (UCPH), Denmark. Her research group operates under the Section for Plant Glycobiology, focusing on metabolic and regulatory networks in plant systems. Her educational background includes a Dipl. Biol. with excellence from the University of Hannover (2001) and a Dr. rer. nat. summa cum laude from Friedrich Schiller Universität Jena (2008). Prior academic positions include Associate Professor at UCPH (2011-2020), Postdoc/Assistant Professor in Plant Biology and Biotechnology (2008-2011), and research positions in Germany. Professor Burow's research centers on plant metabolic networks, particularly investigating how plants integrate internal and external signals through transcriptional, post-transcriptional, and post-translational regulation. Her work primarily utilizes Arabidopsis thaliana and glucosinolates as model systems to study specialized metabolism dynamics. Key research areas include transcription factor networks (particularly R2R3 MYB factors), metabolite sensing, RNA-mediated regulation, and protein-protein interactions in metabolic channeling. Her recent publications (2023-2025) demonstrate strong focus on plant defense mechanisms, glucosinolate metabolism, plant-microbe interactions, and translational applications in horticulture. The research spans molecular genetics, ecological interactions, and agricultural applications, with particular emphasis on Brassicaceae species and their specialized metabolites. As an educator, she serves as Head of Studies for the BSc Biotechnology program and teaches courses including Introduction to Biotechnology, Experimental Molecular Biology, and Big Data in Biotechnology at both undergraduate and graduate levels. Her outreach activities include public engagement events like Kulturnat in 2008-2009 focused on plant biotechnology. Her laboratory investigates the complex regulatory networks controlling plant specialized metabolism, with particular attention to how environmental cues modulate metabolic investments in growth versus defense. Current work integrates molecular techniques with systems biology approaches to understand metabolic plasticity in changing environments.

Frank Wallerمشاهده پروفایل

پژوهشگر

• Plant-Microbe Interactions
• Molecular Plant Pathology
• Sphingolipid Metabolism
• +۳ مورد دیگر

Dr. Frank Waller is a Researcher at the Chair of Pharmaceutical Biology , Julius-Maximilians-University Würzburg since 2009. His work focuses on plant-microbe interactions , particularly the molecular mechanisms of plant pathogen resistance and the role of sphingolipids in stress responses . He leads a research group investigating programmed cell death and endophytic fungal colonization of plant roots. PhD in Biology (University of Freiburg) Postdoc at Nara Institute of Science and Technology, Japan Habilitation in Plant Physiology at Justus Liebig University Giessen His research demonstrates that phytosphingosine inhibits pathogen growth while studying Serendipita indica and Serendipita herbamans endophytes that enhance systemic pathogen resistance and yield in host plants. Current projects analyze sphingolipid metabolism and fusarium resistance mechanisms in wheat. The group maintains an improved growth medium for Serendipita indica propagation. DFG-funded project on sphingobase metabolism (2019) Previous support from Alexander von Humboldt Foundation Collaborations with Japanese Society for the Promotion of Science International projects with East Asia Scholarship Program Key findings include: Phytosphingosine's role in pathogen inhibition Endophyte-induced systemic resistance mechanisms Stress-dependent colonization dynamics